On October 30, the “Big Country New Drug Value Reconstruction - 2026 Health Industry Conference” was held in Qiantang District, Hangzhou. Xu Jin, Deputy District Governor of Qiantang District, said that last year, the region's GDP exceeded 150 billion yuan, and the total industrial output value exceeded 400 billion yuan according to regulations. As the core carrying area of “China Pharmaceutical Port”, the biomedical industry now ranks first in Hangzhou. It has gathered more than 1,800 pharmaceutical companies of various types, and 7 of the world's leading pharmaceutical companies, including Pfizer, have entered clinical trials. A total of 141 innovative drugs have entered the clinical trial stage. This year, 3 first-class innovative drugs were successfully launched, accounting for three-sevenths of Zhejiang Province.

On October 30, the “Big Country New Drug Value Reconstruction - 2026 Health Industry Conference” was held in Qiantang District, Hangzhou. Xu Jin, Deputy District Governor of Qiantang District, said that last year, the region's GDP exceeded 150 billion yuan, and the total industrial output value exceeded 400 billion yuan according to regulations. As the core carrying area of “China Pharmaceutical Port”, the biomedical industry now ranks first in Hangzhou. It has gathered more than 1,800 pharmaceutical companies of various types, and 7 of the world's leading pharmaceutical companies, including Pfizer, have entered clinical trials. A total of 141 innovative drugs have entered the clinical trial stage. This year, 3 first-class innovative drugs were successfully launched, accounting for three-sevenths of Zhejiang Province.